1-11 of 11
M. Golam Mohi
Close
Sort by
Journal Articles

Tyrosine 201 Is Critical for Transformation Mediated by JAK2V617F

Dongqing Yan, M. Golam Mohi
Journal: Blood
Blood (2010) 116 (21): 626.
https://doi.org/10.1182/blood.V116.21.626.626
Published: 2010
Journal Articles

Efficacy of Vorinostat In a Murine Model of Polycythemia Vera

Hajime Akada, Saeko Hamada, M. Golam Mohi
Journal: Blood
Blood (2010) 116 (21): 629.
https://doi.org/10.1182/blood.V116.21.629.629
Published: 2010
Journal Articles

Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera–like disease

Hajime Akada, Dongqing Yan, Haiying Zou, Steven Fiering, Robert E. Hutchison, M. Golam Mohi
Journal: Blood
Blood (2010) 115 (17): 3589–3597.
https://doi.org/10.1182/blood-2009-04-215848
Published: 2010
Includes: Supplemental data
Journal Articles

Conditional Expression of Heterozygous or Homozygous Jak2V617F From Its Endogenous Promoter Induces a Polycythemia Vera-Like Disease.

Hajime Akada, Dongqing Yan, Haiying Zou, Robert E. Hutchison, M. Golam Mohi, PhD
Journal: Blood
Blood (2009) 114 (22): 437.
https://doi.org/10.1182/blood.V114.22.437.437
Published: 2009
Journal Articles

Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis

Gordon Chan, Demetrios Kalaitzidis, Tatiana Usenko, Jeffery L. Kutok, Wentian Yang, M. Golam Mohi, Benjamin G. Neel
Journal: Blood
Blood (2009) 113 (18): 4414–4424.
https://doi.org/10.1182/blood-2008-10-182626
Published: 2009
Includes: Supplemental data
Journal Articles

Distinct Gab2-Mediated Signaling Pathways Are Essential for Myeloid or Lymphoid Transformation and Leukemogenesis by BCR-ABL

M. Golam Mohi, PhD, Wayne W. Chan, BA, Shaoguang Li, MD, PhD, Benjamin Neel, MD, PhD, Richard A. Van Etten, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 570.
https://doi.org/10.1182/blood.V112.11.570.570
Published: 2008
Journal Articles

Differential Biological Properties and Signaling Effects of Different JAK2 Alleles

M. Golam Mohi, PhD, Dongqing Yan, Haiying Zou
Journal: Blood
Blood (2008) 112 (11): 3737.
https://doi.org/10.1182/blood.V112.11.3737.3737
Published: 2008
Journal Articles

Inducible Expression of Leukemia-Associated Shp2 (Ptpn11) Affects Multiple Stages of Hematopoiesis and Causes a Fatal Myeloproliferative Disorder (MPD) in Mice

Gordon Chan, Demetrios Kalaitzidis, M. Golam Mohi, Wentian Yang, Jeffery Kutok, Benjamin Neel
Journal: Blood
Blood (2007) 110 (11): 1529.
https://doi.org/10.1182/blood.V110.11.1529.1529
Published: 2007
Journal Articles

Activating Shp2 Mutations Cause Progressive Myeloproliferative Disorder in Mice.

M. Golam Mohi, PhD, Gordon Chan, Ph.D, Toshiyuki Araki, Ph.D., Wentien Yang, Ph.D., Lily Pao, Ph.D., Demetrios Kalaitzidis, Ph.D., Benjamin G. Neel, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 3614.
https://doi.org/10.1182/blood.V108.11.3614.3614
Published: 2006
Journal Articles

Structural and Signaling Requirements for Transformation Mediated by Shp2 Mutants.

M. Golam Mohi, PhD, Benjamin G. Neel, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 3508.
https://doi.org/10.1182/blood.V106.11.3508.3508
Published: 2005
Journal Articles

Mechanism of Oncogenesis by Leukemia-Associated Mutants of Shp2 (PTPN11).

M. Golam Mohi, Ph.D, Heike Keilhack, Ph.D., Sarah Cohen, Christina Boulton, Toshiyuki Araki, Ph.D., Ifor Williams, M.D., Ph.D., Jeffery L. Kutok, M.D., Ph.D., D. Gary Gilliland, M.D., Ph.D., Benjamin G. Neel, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 199.
https://doi.org/10.1182/blood.V104.11.199.199
Published: 2004